热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易

客户端

　　艾美疫苗（06660）早盘上涨6.36%，现报5.85港元，成交额4254.60万港元。

　　艾美疫苗昨日公布，mRNA带状疱疹疫苗已于近日向中国药品监督管理局药品评审中心申报临床。临床前动物试验中，第三方检测单位的检测结果显示，集团mRNA带状疱疹疫苗特异性T细胞免疫、特异性IgG抗体滴度、膜抗原萤光抗体滴度，均显著高于市售重组亚单位对照疫苗。

海量资讯、精准解读，尽在新浪财经APP

责任编辑：卢昱君

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.